Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Equity Average (2016 - 2025)

Historic Equity Average for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $2.0 billion.

  • Bio-Techne's Equity Average fell 569.91% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 569.91%. This contributed to the annual value of $2.0 billion for FY2025, which is 118.22% down from last year.
  • Latest data reveals that Bio-Techne reported Equity Average of $2.0 billion as of Q4 2025, which was down 569.91% from $1.9 billion recorded in Q3 2025.
  • Bio-Techne's Equity Average's 5-year high stood at $2.1 billion during Q4 2024, with a 5-year trough of $1.5 billion in Q1 2021.
  • Its 5-year average for Equity Average is $1.9 billion, with a median of $1.9 billion in 2023.
  • As far as peak fluctuations go, Bio-Techne's Equity Average soared by 1775.33% in 2021, and later tumbled by 767.39% in 2025.
  • Bio-Techne's Equity Average (Quarter) stood at $1.7 billion in 2021, then increased by 6.82% to $1.8 billion in 2022, then rose by 10.7% to $2.0 billion in 2023, then grew by 6.46% to $2.1 billion in 2024, then decreased by 5.7% to $2.0 billion in 2025.
  • Its Equity Average was $2.0 billion in Q4 2025, compared to $1.9 billion in Q3 2025 and $2.0 billion in Q2 2025.